These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 22975712)

  • 1. Dual action molecules: bioassays of combined novel antioxidants and angiotensin II receptor antagonists.
    Jani NV; Ziogas J; Angus JA; Schiesser CH; Macdougall PE; Grange RL; Wright CE
    Eur J Pharmacol; 2012 Nov; 695(1-3):96-103. PubMed ID: 22975712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous glutathione is essential in the testing of antioxidant capacity using radical-induced haemolysis.
    Jani N; Ziogas J; Angus JA; Wright CE
    J Pharmacol Toxicol Methods; 2012; 65(3):142-6. PubMed ID: 22507255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats.
    Nickenig G; Laufs U; Schnabel P; Knorr A; Paul M; Böhm MP
    Br J Pharmacol; 1997 May; 121(1):134-40. PubMed ID: 9146897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antioxidant effect of hydroxyl-substituent Schiff bases on the free-radical-induced hemolysis of human erythrocytes.
    Tang YZ; Liu ZQ
    Cell Biochem Funct; 2007; 25(2):149-58. PubMed ID: 16170851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
    Masaki H; Kurihara T; Yamaki A; Inomata N; Nozawa Y; Mori Y; Murasawa S; Kizima K; Maruyama K; Horiuchi M; Dzau VJ; Takahashi H; Iwasaka T; Inada M; Matsubara H
    J Clin Invest; 1998 Feb; 101(3):527-35. PubMed ID: 9449684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antioxidative effect of icariin in human erythrocytes against free-radical-induced haemolysis.
    Liu ZQ; Luo XY; Sun YX; Wu W; Liu CM; Liu ZQ; Liu SY
    J Pharm Pharmacol; 2004 Dec; 56(12):1557-62. PubMed ID: 15563763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selenosartans: novel selenophene analogues of milfasartan and eprosartan.
    Grange RL; Ziogas J; North AJ; Angus JA; Schiesser CH
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1241-4. PubMed ID: 18191398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of AT1 receptor-mediated contraction of rat uterine artery by AT2 receptors.
    Zwart AS; Davis EA; Widdop RE
    Br J Pharmacol; 1998 Dec; 125(7):1429-36. PubMed ID: 9884070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous angiotensin II suppresses stretch-induced ANP secretion via AT1 receptor pathway.
    Oh YB; Gao S; Shah A; Kim JH; Park WH; Kim SH
    Peptides; 2011 Feb; 32(2):374-81. PubMed ID: 21056071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Bio-Catalyzer alpha.rho no.11 (Bio-Normalizer) supplementation against peroxyl radical-induced oxidative damage in rat organ homogenates.
    Marcocci L; D'Anna R; Yan LJ; Haramaki N; Packer L
    Biochem Mol Biol Int; 1996 Mar; 38(3):535-41. PubMed ID: 8829613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylcysteine decreases angiotensin II receptor binding in vascular smooth muscle cells.
    Ullian ME; Gelasco AK; Fitzgibbon WR; Beck CN; Morinelli TA
    J Am Soc Nephrol; 2005 Aug; 16(8):2346-53. PubMed ID: 15944340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for evaluation of antioxidant activity based on inhibition of free radical-induced erythrocyte hemolysis.
    Takebayashi J; Chen J; Tai A
    Methods Mol Biol; 2010; 594():287-96. PubMed ID: 20072925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril and 6-mercaptopurine: whose SH possesses higher antioxidant ability?
    Li GX; Liu ZQ
    Eur J Med Chem; 2009 Dec; 44(12):4841-7. PubMed ID: 19692149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vivo effects of irbesartan and losartan on angiotensin II receptor binding in the rat kidney following oral administration.
    Fabiani ME; Dinh DT; Nassis L; Casley DJ; Johnston CI
    Clin Sci (Lond); 2000 Oct; 99(4):331-41. PubMed ID: 10995600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tandem free-radical addition/substitution chemistry and its application to the preparation of novel AT1 receptor antagonists.
    Staples MK; Grange RL; Angus JA; Ziogas J; Tan NP; Taylor MK; Schiesser CH
    Org Biomol Chem; 2011 Jan; 9(2):473-9. PubMed ID: 21049134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of high pacing-induced ANP secretion by antioxidants in isolated rat atria.
    Gao S; Yuan K; Shah A; Kim JS; Park WH; Kim SH
    Peptides; 2011 Dec; 32(12):2467-73. PubMed ID: 22063193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lidocaine has better antioxidant potential than ropivacaine and bupivacaine: in vitro comparison in a model of human erythrocytes submitted to an oxidative stress.
    Lenfant F; Lahet JJ; Courderot-Masuyer C; Freysz M; Rochette L
    Biomed Pharmacother; 2004 May; 58(4):248-54. PubMed ID: 15183851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazole based non-peptide angiotensin II receptor antagonists. Investigation of the effect of the orientation of the imidazole ring on biological activity.
    Wahhab A; Smith JR; Ganter RC; Moore DM; Hondrelis J; Matsoukas J; Moore GJ
    Arzneimittelforschung; 1993 Nov; 43(11):1157-68. PubMed ID: 8292058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of the antioxidant probucol to angiotensin II type I receptor antagonist arrests progressive mesangioproliferative glomerulonephritis in the rat.
    Kondo S; Shimizu M; Urushihara M; Tsuchiya K; Yoshizumi M; Tamaki T; Nishiyama A; Kawachi H; Shimizu F; Quinn MT; Lambeth DJ; Kagami S
    J Am Soc Nephrol; 2006 Mar; 17(3):783-94. PubMed ID: 16467449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo receptor occupancy of the angiotensin II receptor by nonpeptide antagonists: relationship to in vitro affinities and in vivo pharmacologic potency.
    Beauchamp HT; Chang RS; Siegl PK; Gibson RE
    J Pharmacol Exp Ther; 1995 Feb; 272(2):612-8. PubMed ID: 7853174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.